Press release
Cancer Diagnostics Market : Type, Industrial Analysis With Abbott, Roche, Illumina, BD, QIAGEN, Hologic, Inc. , GE Healthcare, Thermo Fisher Scientific, Siemens Healthineers, Becton Dickinson
Cancer Diagnostics Market
The cancer diagnostics market research report delineates the worldwide market measure (regard and volume) and share by makers, type, application, and territory. It introduces all the essential information required to frame upcoming yielding business methodologies for cancer diagnostics industry investigators, specialists, and experts to choose their business systems. Business layout, market share, offering, advantages, and approaches of top players are fused into this cancer diagnostics market research report. The market report examines the cancer diagnostics market which depends on its geographies, exhibit segments, and current market designs
Cancer diagnostics market is expected to rise from its initial estimated value of USD 143.89 billion in 2018 to a projected value of USD 244.28 billion by 2026, registering a CAGR of 6.84% in the forecast period of 2019-2026. This rise in market value can be attributed to innovations and advancements in technological offerings by the major manufacturers(Current Year Updated Statistic Will Be Provided in Report).
Get Free Sample Research Report: http://databridgemarketresearch.com/request-a-sample/?dbmr=global-cancer-diagnostics-market
Cancer diagnostics is the process of detecting various biomarkers, proteins and certain symptoms that result in the detection of presence of cancerous tumor in the patients. The detection of certain biomarkers and proteins that are prevalent in cancer disorders thereby result in the diagnosis process. The process of detecting cancer includes usage of certain technology and devices specifically used in its diagnosis.
Market Drivers
· Significant contribution and investments undertaken by various organizations; this factor is expected to act as a driver for the market growth
· Increasing levels of geriatric population along with the growth in prevalence of cancer; this factor is expected to act as a driver for the market growth
Market Restraints
· High cost of diagnostics procedure for cancers available in the market is expected to act as a restraint to the market growth
· Presence of strict regulations and standards for the approval and commercialization of cancer diagnostic products & services; this factor is expected to act as a restraint to the market growth
Key Developments in the Market:
· In March 2019, NeoGenomics Laboratories, Inc. announced the launch of “Ventana PD-L1 (SP142) Assay” testing for tumor tissue testing in patients with triple negative subtype of breast cancer. The test recently approved by the FDA for patients who might respond to “TECENTRIQ”, an immune checkpoint inhibitor in combination with chemotherapy.
· In December 2018, QIAGEN and NeoGenomics Laboratories, Inc. announced that they had collaborated for the development and commercialization of diagnostic systems for cancer treatments. The agreement gives for the provision of QIAGEN companion diagnostics for the usage in clinical trials approval of oncology treatments until they are approved by the U.S. FDA.
· In October 2018, Telerad Tech announced the launch of a new AI-based breast cancer detection system, “MammoAssist” for the detection of early stage cancer. The system analyses the mammogram results and images and detects the characteristics highlighted in breast cancers.
· In August 2018, BioGenex announced the launch of five new antibodies for usage in cancer immunohistochemistry (IHC). The company’s IHC solution is capable of offering the widest portfolio inclusive of around 400 antibodies, reagents, consumables and ancillaries.
Key Market Competitors:
Abbott; Agilent Technologies, Inc.; BD; bioMérieux SA; NeoGenomics Laboratories, Inc.; Telerad Tech; F. Hoffmann-La Roche Ltd; GENERAL ELECTRIC COMPANY; Hologic Inc.; Illumina, Inc.; QIAGEN; BioGenex; Siemens Healthcare GmbH; BioNTech Diagnostics GmbH; Thermo Fisher Scientific Inc.; Koninklijke Philips N.V.; are few of the major competitors currently present in the market.
For TOC or Buy Full Report, Visit: https://databridgemarketresearch.com/toc/?dbmr=global-cancer-diagnostics-market
Global cancer diagnostics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of cancer diagnostics market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Segmentation: Global Cancer Diagnostics Market
· By Technology
• Instrument Based
o Biopsies
1. Needle Biopsy
2. Endoscopic Biopsy
3. Bone Marrow Biopsy
4. Others
o Liquid Biopsy
i. Diagnostic Imaging
ii. Mammography
iii. Ultrasound
iv. Magnetic Resonance Imaging (MRI)
v. Computed Tomography (CT)
vi. Positron Emission Tomography
1. Standalone Positron Emission Tomography
2. Hybrid Position Emission Tomography
• Platform-Based
o Immunohistochemistry (IHC)
o Flow Cytometry
o In-Situ Hybridization (ISH)
o Polymerase Chain Reaction (PCR)
o Next Generation Sequencing (NGS)
o Microarrays
o Others
• Tumor Biomarker Tests
o Alpha-Fetoprotein (AFP) Tests
o CA-19 Radioimmunoassay Tests
o BRCA Tests
o ALK Tests
o Carcinoembryonic Antigen (CEA) Tests
o KRAS Mutation Tests
o HER2 Tests
o EGFR Mutation Tests
o Circulating Tumor Cells (CTC) Tests
o Prostate-Specific Antigen (PSA) Tests
o Others
· By Application
o Breast Cancer
o Colorectal Cancer
o Cervical Cancer
o Lung Cancer
o Prostate Cancer
o Skin Cancer
o Blood Cancer
o Kidney Cancer
o Pancreatic Cancer
o Ovarian Cancer
o Others
· By End-User
o Cancer Research Institutes
o Diagnostic Laboratories
o Hospitals
o Others
· By Geography
North America
US.
Canada
Mexico
South America
Brazil
Argentina
Rest of South America
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Turkey
Belgium
Netherlands
Switzerland
Rest of Europe
Asia-Pacific
Japan
China
South Korea
India
Australia
Singapore
Thailand
Malaysia
Indonesia
Philippines
Rest of Asia Pacific
Middle East & Africa
South Africa
Egypt
Saudi Arabia
United Arab Emirates
Israel
Rest of Middle East & Africa
Want Full Report? Visit Here For Custom Requirements: http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-cancer-diagnostics-market
Contact Us
Data Bridge Market Research
Toll Free: +1-888-387-2818
Mail: sopan.gedam@databridgemarketresearch.com
http://databridgemarketresearch.com
About Us
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. For Customization and Getting Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Diagnostics Market : Type, Industrial Analysis With Abbott, Roche, Illumina, BD, QIAGEN, Hologic, Inc. , GE Healthcare, Thermo Fisher Scientific, Siemens Healthineers, Becton Dickinson here
News-ID: 1774829 • Views: …
More Releases from Data Bridge Market Research
Water Treatment System Market: Sustaining the Future of Clean Water
Introduction
Understanding Water Treatment Systems
Water treatment systems are designed to purify and disinfect water for various uses-drinking, industrial processes, irrigation, and wastewater reuse. These systems eliminate contaminants such as bacteria, viruses, heavy metals, chemicals, and particulates, making water safe and sustainable for consumption and use.
Importance in Global Sustainability
Clean water is essential to life and industrial progress. With growing water demand and pollution, water treatment systems are now critical infrastructure across the…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
